ALS Therapy Development Institute
ALS Therapy Development Institute
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for ALS Therapy Development Institute? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
To invent and discovery drugs until everyone with ALS has effective treatments.
About
ALS TDI combines the passion and dedication of a nonprofit organization with the entrepreneurial and scientific spirit of a biotechnology company. Our laboratory is the leading drug discovery program for ALS, and it bridges a critical research gap. Our in-house expertise translates research into potential drug candidates by screening drugs in the SOD1 mouse model of ALS. Our scientific collaborations are designed to bring the most promising leads closer to patient use. We share emerging knowledge on the disease with patients, physicians, and researchers as quickly and comprehensively as possible. Every decision is made in the interest of finding effective treatments for people living with ALS. Our unique approach accelerates drug development for ALS.
Interesting data from their 2019 990 filing
The filing outlines the non-profit's goal as “Our mission is to identify viable targets for therapy development and expeditiously manage the creation of those treatments that will arrest the suffering of today's als patients.”.
When explaining its purpose, the activities were outlined as: “We are committed to creating and leading a transparent collaborative research process that involves als patients today and honors those whose journey with this disease has ended. we are guided by passion, love and the spirit of entrepreneurship upon which we were founded.”.
- As per legal reporting requirements, the state of operation for the non-profit is MA.
- The non-profit's address for 2019 is listed as 300 TECHNOLOGY SQUARE NO 400, CAMBRIDGE, MA, 02139 in the filing.
- As per the non-profit's form, they have 70 employees as of 2019.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $2,709,037.
- The organization has 19 independent voting members.
- The organization was formed in 1999.
- The organization pays $5,752,410 in salary, compensation, and benefits to its employees.
- The organization pays $1,084,521 in fundraising expenses.